β₂ adrenergic receptor activation suppresses bone morphogenetic protein (BMP)-induced alkaline phosphatase expression

Takayuki Yamada1, Yoichi Ezura, Tadayoshi Hayata

  • 1Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; Department of Oral and Maxillofacial Surgery, Tokyo Medical and Dental University, Tokyo, Japan; Global COE Program, Tokyo Medical and Dental University, Tokyo, Japan.

Insights

Beta-2 adrenergic stimulation, using isoproterenol, inhibits bone formation markers in osteoblast cells. This beta-2 adrenergic action suppresses alkaline phosphatase expression, a key indicator of bone development.

Area of Science:

  • Bone Biology and Osteoblast Differentiation
  • Adrenergic Signaling Pathways
  • Cellular and Molecular Physiology

Background:

  • Beta-adrenergic stimulation is known to inhibit bone formation in vivo.
  • The precise mechanisms by which beta-adrenergic signaling influences osteoblast differentiation remain unclear.
  • Understanding these effects is crucial for bone health research.

Purpose of the Study:

  • To investigate the impact of beta-2 adrenergic stimulation on osteoblast-like MC3T3-E1 cells.
  • To specifically examine the effects on alkaline phosphatase expression induced by Bone Morphogenetic Proteins (BMPs).
  • To elucidate the molecular pathways involved in this regulation.

Main Methods:

  • Utilized MC3T3-E1 cells, a common model for osteoblast differentiation.
  • Administered isoproterenol (a beta-2 adrenergic agonist) and BMPs to cell cultures.
  • Assessed alkaline phosphatase activity and mRNA expression.
  • Measured BMP-responsive element (BRE)-luciferase activity to study signaling pathways.

Main Results:

  • Isoproterenol significantly suppressed BMP-induced alkaline phosphatase expression in a dose-dependent manner.
  • Suppression was more pronounced at higher cell densities and with continuous isoproterenol treatment.
  • Isoproterenol reduced alkaline phosphatase mRNA levels and inhibited BMP-induced BRE-luciferase activity.
  • These effects were observed even with high BMP concentrations.

Conclusions:

  • Beta-2 adrenergic stimulation, via isoproterenol, negatively regulates BMP-induced alkaline phosphatase expression in osteoblast-like cells.
  • The mechanism involves interference with BMP signaling pathways at the transcriptional level.
  • These findings contribute to understanding the role of adrenergic signaling in bone metabolism and osteoblast function.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.7K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.5K